Background: The concept of developmental hemostasis has been universally accepted. Physiological reference ranges for coagulation tests are available for infants and children of different ages. However, on Oriental children they are rare. 
Introduction
The concept of developmental hemostasis introduced by Andrew et al. (1) (2) (3) in the late 1980s has been universally accepted (4) . The hemostatic system of children is significantly different from that in adults. Thus, an understanding of developmental hemostasis and the development of appropriate age-dependent reference ranges are pivotal for prevention, diagnosis, and treatment of hemostatic problems during childhood (4) (5) (6) (7) . Physiological reference ranges are available for premature infants, full-term infants and children from 1 to 16 years of age (1) (2) (3) (4) (5) (6) (7) (8) (9) . However, most reports are relevant to Caucasians (1) (2) (3) (4) (5) (6) (7) (8) (9) , while studies on developmental hemostasis in Oriental children is rare.
Differences exist in the hemostatic system between different racial/ethnic groups. For example, the incidence and risk of venous thromboembolism (VTE) is markedly lower in Asian/Pacific Islanders than in Caucasians and African Americans (10) (11) (12) (13) (14) . VTE is not as common in Chinese as in Caucasians (15) . Genetic risk factors related to VTE in Caucasians such as factor V Leiden and prothrombin G20210A mutations are rare in Asian, especially in Chinese and Japanese (16) (17) (18) (19) (20) (21) (22) . The mean plasma concentrations of factors VII, VIII and fibrinogen were lower in Japanese than in Caucasians (23) . In the MESA study, Chinese participants had among the highest concentrations of plasminogen activator inhibitor-1, but among the lowest of all other hemostatic factors and endothelial markers (24) . The allele frequency of frequently occurring C--)T polymorphism in the factor XII promoter region at nucleotide (nt) 46 is higher in Orientals than in Caucasians and Europeans (25, 26) . This results in lower plasma factor XII activity in Orientals (25, 27) . These differences stress the importance and necessity for establishing reference ranges for clotting assays related to race.
The activated partial thromboplastin time (APTT) is the most widely used test for identifying abnormalities in the intrinsic and common coagulation pathways, monitoring anticoagulant therapy with unfractionated heparin, and the detection of inhibitors of coagulation, the most common of which is the lupus anticoagulants (LAC) (28) . Shortened APTT values may be associated with hypercoagulability and appear to be significantly associated with increased risk of VTE (28) . There have been several reports concerning age-associated APTT values in healthy children, in which inconsistent conclusions were drawn with respect to values seen in adults (4, 6, (29) (30) (31) . It is recommended that coagulation laboratories devel-op age-related reference ranges specific to their own testing systems for the local population (4, 7, 32) . In this study, we reviewed retrospectively age-associated evolvement of APTT values in healthy Chinese subjects from birth through childhood. We also investigated prospectively the causes of longer APTT values in healthy children compared with adults.
Materials and methods

Study population
Preoperative coagulation data from children aged 0-18 years receiving minor elective surgery in Peking University Shenzhen Hospital, from May 2004 to October 2007 was collected from the hospital information system and patient medical record and reviewed. The hospital is located in Shenzhen, where )80% of the population migrated from other parts of China. Ethical approval was not required in this study, as preoperative coagulation tests including APTT, prothrombin time and platelet count were routinely performed in accordance with document No. (2000) 412 enacted by the Ministry of Health of the P.R. China. To qualify for the study, enrolled subjects had to meet the following criteria: no family history of bleeding or thrombophilia, no history of easy bruising, no history of heart, lung, liver or kidney diseases, normal physical examination, a normal white blood cell count, and no history of medication use for at least two weeks prior to specimen collection. All enrolled healthy neonates and infants from ages 1 to 6 months were full-term, did not experience any perinatal problems, and had no pathological jaundice, infection or malnutrition. Specimens with inappropriate ratio of blood to anticoagulant or hemolysis were excluded from analysis. Individuals who were shown by other laboratory examinations to have diseases affecting blood coagulation were also excluded. Preoperative coagulation examination data from adult control subjects were also reviewed. Subjects in the control group were patients receiving minor elective surgery during the same period. They had no history of hemorrhagic, thrombotic, cardiac, pulmonary, hepatic or renal diseases, and no history of taking medications for at least two weeks prior to collection of specimens.
Laboratory analysis
Blood samples (2 mL) were obtained by venipuncture at the same time that routine blood for preoperative analysis was obtained. The blood was collected directly into a siliconized glass vacutainer (Improve Medical Instrument's Co, Ltd, Guangzhou, China) containing 3.2% (109 mmol/L) buffered sodium citrate with a 9:1 ratio of blood to citrate. The specimens were centrifuged immediately at 2500 g for 15 min at room temperature to prepare platelet-poor plasma (PPP) for the preoperative coagulation screening tests. To investigate the causes of increased APTT values in children compared with adults, from March 2007 to October 2007, PPP from children with APTT values longer than 43.0 s, the upper limit of the adult reference interval, and PPP from adult control subjects were collected immediately after the coagulation screening tests were completed. Samples were frozen at -808C until analysis of coagulation factors and LAC.
All coagulation assays were performed using the ACL Futura coagulation analyzer (Instrumentation Laboratory, Lexington, KY, USA) according to the manufacturer's specifications. For each assay, calibration was performed regularly and control samples measured daily. Coagulation screening tests were completed within 4 h following blood collection. APTT was measured using Lyophilized silica (HemosILீ, Milan, Italy) reagent. This reagent is sensitive to decreased concentrations of intrinsic factors and the presence of heparin anticoagulant. Results were measured in seconds with a clot-based method. Activity of coagulation factors VIII, IX, XI and XII (FVIII:C, FIX:C, FXI:C and FXII:C) were determined using one-stage clotting methods with respective factor-deficient plasma (HemosILீ, Milan, Italy) and the APTT reagent. LAC was assayed using LAC Screen/ LAC Confirm reagent (HemosILீ, Milan, Italy), both of which were improved Diluted Russell's Viper Venom Test (DRVVT) reagents. The LAC Screen reagent is poor in phospholipid, making it sensitive to LAC. Specimens with a LAC Screen ratio (LAC-SR) above 1.2 were confirmed with LAC Confirm reagent, which is rich in phospholipid. Specimens with a normalized LAC ratio above 1.2 were considered to be LAC Confirm positive. The PPP was thawed and allowed to reach room temperature before coagulation factors and LAC were assayed in batch mode.
Statistical analysis
Statistical calculations were performed using SPSS version 17.0. Data are expressed as means with the 2.5th-97.5th percentile in parentheses, or means"1 SD (standard deviation). Non-parametric data were analyzed using the Kruskal-Wallis and Mann-Whitney U-tests. Comparison of the rate of two samples was performed using Fisher's exact probability test. Parametric data were analyzed using Student's t-test. Pearson correlation test was used for correlation.
Results
Study population
A total of 1466 infants and children met the enrollment criteria. Cases that were excluded included 66 cases with inappropriate ratio of blood to anticoagulant, 19 cases with specimen hemolysis, and three cases with increased values of serum alanine aminotransferase. One case of hereditary hypofibrinogenemia, one case of hereditary factor XI deficiency and one case of von Willebrand factor deficiency confirmed by laboratory examination were also excluded. Thus, 1375 infants and children were eligible for this study. We also enrolled 697 adult subjects to serve as a control group. The procedures that were performed on the study subjects are summarized in Table 1 . Demographic features of the study cohort are shown in Table 2 .
Evolvement of APTT values with age
APTT values showed a distinctive pattern of change in childhood (Table 2, Figure 1A) . APTT values in neonates were longest, followed by infants aged 1-6 months. APTT values in infants aged 6-12 months were significantly shorter than those in infants aged 1-6 months (ps0.000), approaching adult values but statistically different from adult values (ps0.017). The hemostatic system changed gradually with increases in age. No significant differences were found between APTT values in children aged 1-2 years and adults (p)0.05). However, APTT values showed a tendency for prolongation, significant differences being found in children aged 3 years (ps0.034) and aged 4-8 years (ps0.000) when compared with adults. Starting at 9 years of age, APTT values shortened gradually, and approached adult levels by age 18. However, these values were still different from those seen in adults (ps0.038).
Comparison of APTT values in children at different ages showed that no significant differences were found in children aged 6 months to 3 years, 4-8 years and 9-18 years, respectively. Thus, data in these age groups were combined for statistical analysis. The mean APTT value in the group of children 6 months to 3 years of age, consisting of 237 infants and children, was 38 Figure 1B .
Lower FXII and FIX, and presence of LAC contributing to the prolongation of APTT values in children
To explore the causes of prolongation of APTT values in children, PPP from 47 children with prolonged APTT value and PPP from 34 adult controls were collected between March 2007 and October 2007 (Table  3) . FVIII:C, FIX:C, FXI:C, FXII:C and LAC were measured in batches after thawing of PPP. The results showed that FXII:C and FIX:C were significantly lower in PPP from children compared with controls (ps0.000). FVIII:C and FXI:C were not significantly different between the two groups (ps0.709 and 0.280, respectively) ( Table 3) . Although the mean LAC-SR seemed higher in PPP from children compared with controls, the difference was not statistically significant (ps0.073). Although five LAC Confirm positive cases (10.6%) were found in PPP from children and none in controls, no significant difference existed between The above results indicated that lower concentrations of FXII:C and FIX:C, and the presence of LAC 
Discussion
The hemostatic system evolves in a manner that is age-dependent (5, 8) . Plasma concentrations of most pro-and anticoagulant proteins are decreased throughout childhood. However, they provide effective hemostatic balance at a lower level compared with adults (5, 6) . This situation necessitates the generation of several appropriate age-dependent reference ranges to interpret laboratory data in pediatric patients and prevent misclassification of children having defects of factors and inhibitors of the coagulation system (7). Since there are differences in the hemostatic system among different racial/ethnic groups (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) , and also between different analyzer and reagent systems (4), coagulation laboratories should develop age-related reference ranges specific to their own testing systems for the local population (4, 7, 32) . In this study, we analyzed retrospectively the results of preoperative APTT testing in childhood and adult controls undergoing minor elective surgery. We evaluated age-dependent development and maturation of the intrinsic coagulation system in healthy Chinese children. Our results showed that APTT values evolved with age and displayed a distinctive pattern of development in childhood. This confirms the concept of developmental hemostasis as elucidated by Andrew et al. (1-3) . Due to different analyzer and reagent systems used, comparison of numerical differences in APTT values in children in this study with studies on other children (1-6, 8, 9, 29-31 ) is inappropriate. The adult APTT normal range in this study (29.19-44.43 s) is longer than that in Caucasian adults (24.6-36.0 s) (33) when the same analyzer and reagent systems were used.
The prolonged APTT values in neonates could be explained by markedly decreased plasma concentrations of the vitamin K-dependent factors (1, 8, 34) and contact factors, and partially by insufficient ratios of plasma to citrate caused by higher hematocrits (35) . APTT values were also markedly prolonged in infants aged 1-6 months, which could be due to the hemostatic system of infants -6 months of age not being fully mature (6, 7) . However, as healthy full-term neonates and infants aged 1-6 months who undergo minor elective operations in our hospital are uncommon, this study cannot elucidate in detail the changes in APTT values on different days following birth, which was one limitation of this study.
Near-adult values are achieved for most coagulation components by 6 months of age (1, 3) . APTT values in infants aged 6-12 months were significantly shortened compared with infants aged 1-6 months (ps0.000) and approximated adult values. No significant differences were found between APTT values in children aged 1-2 years and adults (p)0.05). This finding could be explained by development of the hemostatic system with age. Interestingly, APTT values showed a tendency for prolongation with significant differences seen in children 3 years of age (ps0.034) and 4-8 years of age (ps0.000) compared with adults. From 9 years of age, APTT values gradually shortened, which could be ascribed to maturation of the hemostatic system.
Prolongation of the APTT is commonly due to decreased levels of contact factors (XI, XII, prekalikrein, high molecular weight kininogen), factors VIII and IX, and the presence of LAC (28, 31, 36) . During the neonatal period, only low titers of factor XII appear to contribute significantly to the abnormal prolongation in APTT, while relative deficiencies of prekalikrein and high molecular weight kininogen usually do not have such effects (37) . Our results suggest that decreased concentrations of FXII:C and FIX:C, and the presence of LAC contributed to the prolongation of APTT values in children. This differs slightly from the conclusion of Gallistl et al. (31) about causes for prolongation of the APTT in healthy Caucasian children. These authors suggest that APTT prolongation is caused by the combination of slightly lower clotting factors (VIII, IX, XII and HMWK). However, several studies (1, 6, 8, 37) have shown that the plasma factor VIII level in children was similar to that of adults, and even reached adult values at birth. Decreased levels of FXII:C and FIX:C in children in this study are consistent with the results of Monagle et al. (4), Andrew et al. (6) and Gallistl et al. (31) . Low factor XII is a common finding in otherwise normal individuals (28, 36, 38) . This finding accounted for nearly half (7/16) of the prolonged APTT values seen in a healthy Austrian population (38) . Plasma factor XII activity concentrations in Orientals are lower than those seen in Caucasians due to higher allele frequency of frequently occurring C--)T polymorphism in the factor XII promoter region at nucleotide (nt) 46 (25) (26) (27) . This could partially explain the contribution of a markedly decreased FXII:C to prolongation of the APTT in healthy Chinese children.
The prevalence of transient and asymptomatic antiphospholipid antibodies (aPL) and/or LAC are more common in children than in adults (39) (40) (41) (42) (43) (44) , which can be partly ascribed to acquired infections (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) . Since children suffer from infections more often than adults, this might explain why children had a much higher prevalence for LAC than adults (42) , especially in early childhood (43, 44) . Male et al. (43) reported that the prevalence of LAC in children peaked at 5 years of age. Similarly, Currimbhoy (44) found a significantly higher prevalence of LAC positivity not associated with symptoms in children younger than 12 years of age compared with older children (3.1% vs. 0.5%). This may partially explain the age-associated phenomenon that APTT values displayed a tendency for prolongation in children after the age of 3 years, and gradually shortened after 9 years.
A frequent association of transient aPL and/or LAC with low factor XII exists (45, 48, 49) . This suggests that aPL and/or LAC play a role in the pathogenesis of decreased factor XII in children. However, no correlation between clotting tests indicative of LAC and aPL (42) , and no correlation of increased APTT with abnormal thromboplastin inhibition or increased aPL (31) were observed. During childhood, LAC may be transient, and the longest persistent feature is a prolongation of clotting tests, even when aPL and phospholipid-dependent tests are no longer positive (43, 47) . LAC-SR correlated weakly with FXII:C and APTT in this study, suggesting that decreased FXII:C concentrations caused by LAC do not play a key role in the mechanisms of APTT prolongation in children.
Our results show a distinct developmental pattern of age-related APTT values and causes of APTT prolongation in otherwise healthy Chinese children. These data will be helpful for accurate diagnosis and management of neonates and children with suspected bleeding or clotting disorders. Although routine coagulation testing to predict postoperative bleeding risk in unselected patients prior to surgery or other invasive procedures is not recommended (36, 50) , our results combined with bleeding scores from structured clinical histories (36, 50) should reduce investigation of otherwise healthy Chinese children who are found to have mildly increased APTT values compared with adults, where routine coagulation tests are performed according to regulations.
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